The Canadian Competition Bureau recently released a report on the price of generic drugs in Canada and indicated therein that although many generic manufacturers offer up to 40% rebates on generic drugs, pharmacies are not passing these rebates on to consumers.

This report has caught the attention of at least one pharmacy association, which has responded by stating that pharmacy services are underfunded by governments, thus pharmacies use manufatures rebates to help fill the funding gap left by governments. For example, the association claims that rebates are used by pharmacies to help offset other benefits offered by pharmacies such as counselling and consulting with patients. Regardless, the Bureau has indicated that it will investigate how to shift rebates offered by generic manufacturers from pharmacies to public and private insurers and consumers.

For more information, please see: